Cell and Gene Therapy Bioprocessing and Commercialization

The 6th Annual Cell and Gene Therapy BioProcessing and Commercialization conference has built a reputation of providing a first-rate faculty of participants, who collectively share perspectives and lessons learned from detailed case studies to help you overcome the challenges, develop the strategies and implement the technologies to propel this field towards commercial sustainability. The event will be held October 5-7, 2016 at Boston Convention and Exhibition Center in Boston, MA.

Connecting cell and gene therapy leaders to drive manufacturing and commercialisation through direct access to innovative discovery, product development and regulatory know-how Learn and benchmark with attendees from the main cell, gene and immunotherapy communities Optimise your process, manufacturing capabilities and analytical strategies

• How do you deal with the challenge of CMO selection, process transfer, and demonstration of comparability?
• What are the requirements for the commercial manufacturing process?
• What other steps must be taken in order to launch large scale manufacturing?
• What is best practise for defining the efficacy of your product?
Ensure stringent cold chain and process automation strategies
• How do you develop a stringent, commercially viable manufacturing strategy?
• How do you bring bioprocessing technologies to these therapies to allow them to be made for the masses?
• What is best practise for keeping costs down in scale-out systems?
• How do you design facilities to make them financially feasible?

Learn how to accelerate preclinical studies and push products into the clinic Successful clinical strategies and regulatory intelligence for efficient development Optimise your time out of the office and benefit from 3 days of additional content with our workshops With thanks to our 2016 advisory board of leading industry experts Network over 2 days with cell and gene therapy industry decision makers 300 Attendees